{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:49:10Z","timestamp":1795031350984,"version":"4.10.2"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Sichuan Province Department of Science and Technology","doi-asserted-by":"publisher","award":["2023ZYD0046"],"award-info":[{"award-number":["2023ZYD0046"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017592","name":"Key Science and Technology Program of Shaanxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304454"],"award-info":[{"award-number":["82304454"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.biopha.2024.117581","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T08:17:04Z","timestamp":1729325824000},"page":"117581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Potential antitumor activity of triptolide and its derivatives: Focused on gynecological and breast cancers"],"prefix":"10.1016","volume":"180","author":[{"given":"Mengjie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5977-9579","authenticated-orcid":false,"given":"Yongxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biopha.2024.117581_bib1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41568-023-00602-5","article-title":"Cancers make their own luck: theories of cancer origins","volume":"23","author":"Jassim","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2024.117581_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.biopha.2024.117581_bib3","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2024.117581_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102396","article-title":"GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer: a position paper from the gynecologic cancer Intergroup (GCIG) symptom benefit committee","volume":"107","author":"Woopen","year":"2022","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.biopha.2024.117581_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcancer.2019.12.012","article-title":"Drug repurposing for cancer therapy, easier said than done","volume":"68","author":"Gonzalez-Fierro","year":"2021","journal-title":"Semin Cancer Biol."},{"issue":"5","key":"10.1016\/j.biopha.2024.117581_bib6","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/cam4.2108","article-title":"Traditional Chinese medicine as a cancer treatment: modern perspectives of ancient but advanced science","volume":"8","author":"Xiang","year":"2019","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.biopha.2024.117581_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21050559","article-title":"The traditional medicine and modern medicine from natural products","volume":"21","author":"Yuan","year":"2016","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.biopha.2024.117581_bib8","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s13346-020-00827-z","article-title":"Therapeutic applications and delivery systems for triptolide","volume":"10","author":"Viegas","year":"2020","journal-title":"Drug Deliv. Transl. Res"},{"issue":"4","key":"10.1016\/j.biopha.2024.117581_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1631\/jzus.B1900607","article-title":"Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects","volume":"21","author":"Song","year":"2020","journal-title":"J. Zhejiang Univ. Sci. B"},{"issue":"38","key":"10.1016\/j.biopha.2024.117581_bib10","doi-asserted-by":"crossref","first-page":"61246","DOI":"10.18632\/oncotarget.10868","article-title":"Overcoming chemoresistance in prostate cancer with Chinese medicine Tripterygium wilfordii via multiple mechanisms","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2024.117581_bib11","doi-asserted-by":"crossref","first-page":"1018273","DOI":"10.3389\/fphar.2022.1018273","article-title":"Quantification of promoting efficiency and reducing toxicity of Traditional Chinese Medicine: a case study of the combination of Tripterygium wilfordii hook. f. and Lysimachia christinae hance in the treatment of lung cancer","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharm."},{"issue":"20","key":"10.1016\/j.biopha.2024.117581_bib12","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1021\/ja00775a078","article-title":"Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii","volume":"94","author":"Kupchan","year":"1972","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.biopha.2024.117581_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.tips.2019.03.002","article-title":"Triptolide and its derivatives as cancer therapies","volume":"40","author":"Noel","year":"2019","journal-title":"Trends Pharm. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2024.117581_bib14","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3892\/ijo.2014.2280","article-title":"Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1","volume":"44","author":"Nakazato","year":"2014","journal-title":"Int J. Oncol."},{"key":"10.1016\/j.biopha.2024.117581_bib15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.biopha.2018.05.088","article-title":"Broad targeting of triptolide to resistance and sensitization for cancer therapy","volume":"104","author":"Hou","year":"2018","journal-title":"Biomed. Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2024.117581_bib16","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1158\/1535-7163.MCT-09-0549","article-title":"Triptolide is an inhibitor of RNA polymerase I and II-dependent transcription leading predominantly to down-regulation of short-lived mRNA","volume":"8","author":"Visp\u00e9","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.biopha.2024.117581_bib17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nchembio.522","article-title":"XPB, a subunit of TFIIH, is a target of the natural product triptolide","volume":"7","author":"Titov","year":"2011","journal-title":"Nat. Chem. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117581_bib18","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/anie.201408817","article-title":"Covalent modification of a cysteine residue in the XPB subunit of the general transcription factor TFIIH through single epoxide cleavage of the transcription inhibitor triptolide","volume":"54","author":"He","year":"2015","journal-title":"Angew. Chem. Int Ed. Engl."},{"issue":"1","key":"10.1016\/j.biopha.2024.117581_bib19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jss.2010.04.047","article-title":"Role of Hsp-70 in triptolide-mediated cell death of neuroblastoma","volume":"163","author":"Antonoff","year":"2010","journal-title":"J. Surg. Res"},{"issue":"19","key":"10.1016\/j.biopha.2024.117581_bib20","doi-asserted-by":"crossref","first-page":"9407","DOI":"10.1158\/0008-5472.CAN-07-1077","article-title":"Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70","volume":"67","author":"Phillips","year":"2007","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.biopha.2024.117581_bib21","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/cbic.201100007","article-title":"Triptolide directly inhibits dCTP pyrophosphatase","volume":"12","author":"Corson","year":"2011","journal-title":"Chembiochem"},{"issue":"1","key":"10.1016\/j.biopha.2024.117581_bib22","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3892\/ol.2021.12823","article-title":"Triptolide inhibits matrix metalloproteinase-9 expression and invasion of breast cancer cells through the inhibition of NF-\u03baB and AP-1 signaling pathways","volume":"22","author":"Hong","year":"2021","journal-title":"Oncol. Lett."},{"issue":"12","key":"10.1016\/j.biopha.2024.117581_bib23","article-title":"Phytochemicals attenuating aberrant activation of \u03b2-catenin in cancer cells","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2024.117581_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.704001","article-title":"TPL inhibits the invasion and migration of drug-resistant ovarian cancer by targeting the PI3K\/AKT\/NF-\u03baB-signaling pathway to inhibit the polarization of M2 TAMs","volume":"11","author":"Le","year":"2021","journal-title":"Front Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2024.117581_bib25","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8020","article-title":"Triptolide inhibits JAK2\/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin\u2011resistant SKOV3\/DDP ovarian cancer cells","volume":"45","author":"Zhong","year":"2021","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2024.117581_bib26","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1039\/D0NP00054J","article-title":"Triptolide: reflections on two decades of research and prospects for the future","volume":"38","author":"Tong","year":"2021","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.biopha.2024.117581_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114705","article-title":"A comprehensive review on celastrol, triptolide and triptonide: insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes","volume":"162","author":"Song","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"13-14","key":"10.1016\/j.biopha.2024.117581_bib28","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.intimp.2005.06.009","article-title":"5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide analog mediates immunosuppressive effects in vitro and in vivo","volume":"5","author":"Zhou","year":"2005","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117581_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2012.05.004","article-title":"5R)-5-hydroxytriptolide (LLDT-8), a novel immunosuppressant in clinical trials, exhibits potent antitumor activity via transcription inhibition","volume":"324","author":"Wang","year":"2012","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.biopha.2024.117581_bib30","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/aps.2012.108","article-title":"Immunosuppressant discovery from Tripterygium wilfordii Hook f: the novel triptolide analog (5R)-5-hydroxytriptolide (LLDT-8)","volume":"33","author":"Tang","year":"2012","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2024.117581_bib31","article-title":"5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study","volume":"34","author":"Cao","year":"2023","journal-title":"Lancet Reg. Health West Pac."},{"key":"10.1016\/j.biopha.2024.117581_bib32","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.biopha.2017.06.041","article-title":"LLDT-288, a novel triptolide analogue exhibits potent antitumor activity in vitro and in vivo","volume":"93","author":"Xu","year":"2017","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.117581_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s12885-016-2487-7","article-title":"The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer","volume":"16","author":"Reno","year":"2016","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2024.117581_bib34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/leu.2011.246","article-title":"MRx102, a triptolide derivative, has potent antileukemic activity in vitro and in a murine model of AML","volume":"26","author":"Carter","year":"2012","journal-title":"Leukemia"},{"issue":"4 Suppl","key":"10.1016\/j.biopha.2024.117581_bib35","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.pan.2015.05.472","article-title":"Minnelide, a novel drug for pancreatic and liver cancer","volume":"15","author":"Banerjee","year":"2015","journal-title":"Pancreatology"},{"issue":"156","key":"10.1016\/j.biopha.2024.117581_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004334","article-title":"A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer","volume":"4","author":"Chugh","year":"2012","journal-title":"Sci. Transl. Med"},{"issue":"9","key":"10.1016\/j.biopha.2024.117581_bib37","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1158\/1078-0432.CCR-13-2947","article-title":"CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide","volume":"20","author":"Banerjee","year":"2014","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2024.117581_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215591","article-title":"Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancreatic cancer","volume":"537","author":"Modi","year":"2022","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.biopha.2024.117581_bib39","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/oncolo\/oyad278","article-title":"First-in-human phase i study of minnelide in patients with advanced gastrointestinal cancers: safety, pharmacokinetics, pharmacodynamics, and antitumor activity","volume":"29","author":"Borazanci","year":"2024","journal-title":"Oncologist"},{"key":"10.1016\/j.biopha.2024.117581_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.intimp.2018.12.058","article-title":"PG490-88, a derivative of triptolide, suppresses ischemia\/reperfusion-induced lung damage by maintaining tight junction barriers and targeting multiple signaling pathways","volume":"68","author":"Pao","year":"2019","journal-title":"Int Immunopharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2024.117581_bib41","first-page":"855","article-title":"PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy","volume":"2","author":"Fidler","year":"2003","journal-title":"Mol. Cancer Ther."},{"issue":"10","key":"10.1016\/j.biopha.2024.117581_bib42","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.ejca.2009.01.026","article-title":"Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours","volume":"45","author":"Kitzen","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"28","key":"10.1016\/j.biopha.2024.117581_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301328","article-title":"A dual stimuli-responsive nanoplatform loaded Pt(IV) -triptolide prodrug for achieving synergistic therapy toward breast cancer","volume":"12","author":"Fang","year":"2023","journal-title":"Adv. Health Mater."},{"issue":"3","key":"10.1016\/j.biopha.2024.117581_bib44","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ejpb.2008.07.017","article-title":"Anti-tumour and immuno-modulation effects of triptolide-loaded polymeric micelles","volume":"70","author":"Xu","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.117581_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s13346-019-00665-8","article-title":"Combination of metronomic administration and target delivery strategies to improve the anti-angiogenic and anti-tumor effects of triptolide","volume":"10","author":"Cai","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"issue":"6","key":"10.1016\/j.biopha.2024.117581_bib46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.apsb.2015.09.006","article-title":"Pharmacokinetic and pharmacodynamic study of triptolide-loaded liposome hydrogel patch under microneedles on rats with collagen-induced arthritis","volume":"5","author":"Chen","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.biopha.2024.117581_bib47","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/09205063.2015.1131667","article-title":"Enhancement of triptolide-loaded micelles on tumorigenicity inhibition of human ovarian cancer","volume":"27","author":"Wang","year":"2016","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"25","key":"10.1016\/j.biopha.2024.117581_bib48","doi-asserted-by":"crossref","first-page":"29827","DOI":"10.1021\/acsami.3c03068","article-title":"ROS Responsive nanoparticles encapsulated with natural medicine remodel autophagy homeostasis in breast cancer","volume":"15","author":"Zhang","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.biopha.2024.117581_bib49","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12943-023-01849-0","article-title":"Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics","volume":"22","author":"Gajbhiye","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2024.117581_bib50","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40164-020-00192-0","article-title":"CD44 as a tumor biomarker and therapeutic target","volume":"9","author":"Xu","year":"2020","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2024.117581_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118721","article-title":"Triptolide-loaded nanoparticles targeting breast cancer in vivo with reduced toxicity","volume":"572","author":"Zheng","year":"2019","journal-title":"Int J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.117581_bib52","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12951-021-00934-0","article-title":"Novel CD44-targeting and pH\/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis","volume":"19","author":"Shi","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117581_bib53","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1021\/jacs.9b10510","article-title":"Molecularly engineering triptolide with aptamers for high specificity and cytotoxicity for triple-negative breast cancer","volume":"142","author":"He","year":"2020","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.biopha.2024.117581_bib54","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1166\/jbn.2017.2429","article-title":"pH Sensitive triptolide-loaded liposome calcium phosphate nanoparticles exhibit enhanced anti-tumor activities against ovarian cancer without damaging the reproductive system","volume":"13","author":"Ru","year":"2017","journal-title":"J. Biomed. Nanotechnol."},{"issue":"38","key":"10.1016\/j.biopha.2024.117581_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202003398","article-title":"Enhanced photothermal therapy through the in situ activation of a temperature and redox dual-sensitive nanoreservoir of triptolide","volume":"16","author":"Liu","year":"2020","journal-title":"Small"},{"issue":"11","key":"10.1016\/j.biopha.2024.117581_bib56","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.apsb.2020.05.011","article-title":"Injectable thermo-responsive nano-hydrogel loading triptolide for the anti-breast cancer enhancement via localized treatment based on \"two strikes\" effects","volume":"10","author":"Luo","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"10","key":"10.1016\/j.biopha.2024.117581_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/cells12101416","article-title":"Current strategies for exosome cargo loading and targeting delivery","volume":"12","author":"Zeng","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2024.117581_bib58","first-page":"2595801","article-title":"The effect of triptolide-loaded exosomes on the proliferation and apoptosis of human ovarian cancer SKOV3 cells","volume":"2019","author":"Liu","year":"2019","journal-title":"Biomed. Res Int"},{"issue":"3","key":"10.1016\/j.biopha.2024.117581_bib59","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1166\/jbn.2021.3041","article-title":"Functional exosome-mediated delivery of triptolide endowed with targeting properties as chemotherapy carriers for ovarian carcinoma","volume":"17","author":"He","year":"2021","journal-title":"J. Biomed. Nanotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117581_bib60","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12951-022-01264-5","article-title":"Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer","volume":"20","author":"Li","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"35","key":"10.1016\/j.biopha.2024.117581_bib61","doi-asserted-by":"crossref","first-page":"41337","DOI":"10.1021\/acsami.3c08003","article-title":"Glycyrrhizic acid-lipid framework nanovehicle loading triptolide for combined immunochemotherapy","volume":"15","author":"Xu","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.biopha.2024.117581_bib62","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12951-022-01389-7","article-title":"Delivery of triptolide: a combination of traditional Chinese medicine and nanomedicine","volume":"20","author":"Sun","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"10","key":"10.1016\/j.biopha.2024.117581_bib63","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1166\/jbn.2018.2633","article-title":"Co-Delivery of triptolide and curcumin for ovarian cancer targeting therapy via mPEG-DPPE\/CaP nanoparticle","volume":"14","author":"Liu","year":"2018","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.biopha.2024.117581_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122092","article-title":"Development of local injectable, bone-targeting nanocarriers of triptolide for treatment of bone-only metastasis","volume":"625","author":"Wen","year":"2022","journal-title":"Int J. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2024.117581_bib65","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3892\/ijo_00000769","article-title":"Triptolide inactivates Akt and induces caspase-dependent death in cervical cancer cells via the mitochondrial pathway","volume":"37","author":"Kim","year":"2010","journal-title":"Int J. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117581_bib66","first-page":"3929","article-title":"Triptolide induces protective autophagy and apoptosis in human cervical cancer cells by downregulating Akt\/mTOR activation","volume":"16","author":"Qin","year":"2018","journal-title":"Oncol. Lett."},{"issue":"Pt 11","key":"10.1016\/j.biopha.2024.117581_bib67","first-page":"2502","article-title":"The genetic depletion or the triptolide inhibition of TFIIH in p53-deficient cells induces a JNK-dependent cell death in Drosophila","volume":"126","author":"Villica\u00f1a","year":"2013","journal-title":"J. Cell Sci."},{"issue":"5","key":"10.1016\/j.biopha.2024.117581_bib68","first-page":"2202","article-title":"Minnelide, a prodrug, inhibits cervical cancer growth by blocking HPV-induced changes in p53 and pRb","volume":"11","author":"Ramakrishnan","year":"2021","journal-title":"Am. J. Cancer Res"},{"issue":"5","key":"10.1016\/j.biopha.2024.117581_bib69","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.7314\/APJCP.2013.14.5.3041","article-title":"Enhanced anti-tumor efficacy of aspirin combined with triptolide in cervical cancer cells","volume":"14","author":"Chen","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"2","key":"10.1016\/j.biopha.2024.117581_bib70","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2010.05.012","article-title":"Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells","volume":"297","author":"Li","year":"2010","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2024.117581_bib71","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3892\/mmr.2013.1783","article-title":"Triptolide induces apoptosis in endometrial cancer via a p53\u2011independent mitochondrial pathway","volume":"9","author":"Wang","year":"2014","journal-title":"Mol. Med Rep."},{"issue":"11","key":"10.1016\/j.biopha.2024.117581_bib72","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.7314\/APJCP.2015.16.11.4571","article-title":"The inhibition effect of triptolide on human endometrial carcinoma cell line HEC-1B: a in vitro and in vivo Studies","volume":"16","author":"Ni","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.biopha.2024.117581_bib73","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1476-4598-9-268","article-title":"Increased accumulation of hypoxia-inducible factor-1\u03b1 with reduced transcriptional activity mediates the antitumor effect of triptolide","volume":"9","author":"Zhou","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2024.117581_bib74","first-page":"1","article-title":"Triptolide transcriptionally represses HER2 in ovarian cancer cells by targeting NF-\u03baB","volume":"2012","author":"Ou","year":"2012","journal-title":"Evid. -Based Complement. Altern. Med."},{"issue":"7","key":"10.1016\/j.biopha.2024.117581_bib75","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12032-014-0014-8","article-title":"Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas","volume":"31","author":"Wu","year":"2014","journal-title":"Med Oncol."},{"key":"10.1016\/j.biopha.2024.117581_bib76","article-title":"Discovery of potential targets of Triptolide through inverse docking in ovarian cancer cells","volume":"8","author":"Wu","year":"2020","journal-title":"PeerJ"},{"issue":"9","key":"10.1016\/j.biopha.2024.117581_bib77","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12032-019-1303-z","article-title":"EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment","volume":"36","author":"Wang","year":"2019","journal-title":"Med Oncol."},{"issue":"9951","key":"10.1016\/j.biopha.2024.117581_bib78","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.biopha.2024.117581_bib79","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.4161\/cc.8.19.9751","article-title":"Involvement of MKP-1 and Bcl-2 in acquired cisplatin resistance in ovarian cancer cells","volume":"8","author":"Wang","year":"2009","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.biopha.2024.117581_bib80","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3892\/ol.2013.1524","article-title":"Triptolide avoids cisplatin resistance and induces apoptosis via the reactive oxygen species\/nuclear factor-\u03baB pathway in SKOV3(PT) platinum-resistant human ovarian cancer cells","volume":"6","author":"Zhong","year":"2013","journal-title":"Oncol. Lett."},{"issue":"14","key":"10.1016\/j.biopha.2024.117581_bib81","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.7150\/jca.16178","article-title":"Anti-cancer and sensibilisation effect of triptolide on human epithelial ovarian cancer","volume":"7","author":"Hu","year":"2016","journal-title":"J. Cancer"},{"issue":"16","key":"10.1016\/j.biopha.2024.117581_bib82","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.4155\/fmc-2018-0108","article-title":"Triptolide antagonized the cisplatin resistance in human ovarian cancer cell line A2780\/CP70 via hsa-mir-6751","volume":"10","author":"Wang","year":"2018","journal-title":"Future Med Chem."},{"issue":"13","key":"10.1016\/j.biopha.2024.117581_bib83","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.7150\/jca.30669","article-title":"Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of AKT","volume":"10","author":"Huang","year":"2019","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2024.117581_bib84","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/CAD.0000000000000894","article-title":"Antitumor activity of triptolide in SKOV3 cells and SKOV3\/DDP in vivo and in vitro","volume":"31","author":"Hu","year":"2020","journal-title":"Anticancer Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2024.117581_bib85","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000112419","article-title":"Role of triptolide as an adjunct chemotherapy for ovarian cancer","volume":"54","author":"Westfall","year":"2008","journal-title":"Chemotherapy"},{"issue":"7","key":"10.1016\/j.biopha.2024.117581_bib86","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.7314\/APJCP.2013.14.7.4267","article-title":"Combined effects of curcumin and triptolide on an ovarian cancer cell line","volume":"14","author":"Cai","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"3","key":"10.1016\/j.biopha.2024.117581_bib87","first-page":"1191","article-title":"Inhibition effect of triptolide on human epithelial ovarian cancer via adjusting cellular immunity and angiogenesis","volume":"39","author":"Hu","year":"2018","journal-title":"Oncol. Rep."},{"issue":"23","key":"10.1016\/j.biopha.2024.117581_bib88","doi-asserted-by":"crossref","first-page":"9334","DOI":"10.1021\/acs.jmedchem.5b01329","article-title":"Phosphonooxymethyl prodrug of triptolide: synthesis, physicochemical characterization, and efficacy in human colon adenocarcinoma and ovarian cancer xenografts","volume":"58","author":"Patil","year":"2015","journal-title":"J. Med Chem."},{"issue":"2","key":"10.1016\/j.biopha.2024.117581_bib89","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ygyno.2014.08.031","article-title":"Inhibition of epithelial ovarian cancer by Minnelide, a water-soluble pro-drug","volume":"135","author":"Rivard","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"16","key":"10.1016\/j.biopha.2024.117581_bib90","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1021\/jm900342g","article-title":"Design and synthesis of novel C14-hydroxyl substituted triptolide derivatives as potential selective antitumor agents","volume":"52","author":"Li","year":"2009","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2024.117581_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106535","article-title":"Breast cancer: Biology, biomarkers, and treatments","volume":"84","author":"Barzaman","year":"2020","journal-title":"Int Immunopharmacol."},{"issue":"21","key":"10.1016\/j.biopha.2024.117581_bib92","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.4161\/cbt.8.21.9803","article-title":"Triptolide: an inhibitor of a disintegrin and metalloproteinase 10 (ADAM10) in cancer cells","volume":"8","author":"Soundararajan","year":"2009","journal-title":"Cancer Biol. Ther."},{"issue":"9","key":"10.1016\/j.biopha.2024.117581_bib93","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3858\/emm.2009.41.9.074","article-title":"Triptolide-induced suppression of phospholipase D expression inhibits proliferation of MDA-MB-231 breast cancer cells","volume":"41","author":"Kang","year":"2009","journal-title":"Exp. Mol. Med"},{"issue":"11","key":"10.1016\/j.biopha.2024.117581_bib94","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.phymed.2009.03.021","article-title":"Effects of triptolide from Tripterygium wilfordii on ER\u03b1 and p53 expression in two human breast cancer cell lines","volume":"16","author":"Liu","year":"2009","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.biopha.2024.117581_bib95","first-page":"830","article-title":"Triptolide inhibits vascular endothelial growth factor-mediated angiogenesis in human breast cancer cells","volume":"16","author":"Liu","year":"2018","journal-title":"Exp. Ther. Med"},{"issue":"3-4","key":"10.1016\/j.biopha.2024.117581_bib96","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ddr.21387","article-title":"Antiestrogenic activity of triptolide in human breast cancer cells MCF-7 and immature female mouse","volume":"78","author":"Tang","year":"2017","journal-title":"Drug Dev. Res."},{"issue":"5","key":"10.1016\/j.biopha.2024.117581_bib97","first-page":"1315","article-title":"Effect of triptolide on focal adhesion kinase and survival in MCF-7 breast cancer cells","volume":"26","author":"Tan","year":"2011","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2024.117581_bib98","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mehy.2011.03.034","article-title":"Does triptolide induce lysosomal-mediated apoptosis in human breast cancer cells?","volume":"77","author":"Messina","year":"2011","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.biopha.2024.117581_bib99","first-page":"557","article-title":"Triptolide induces lysosomal-mediated programmed cell death in MCF-7 breast cancer cells","volume":"5","author":"Owa","year":"2013","journal-title":"Int J. Women\u2019s. Health"},{"issue":"1","key":"10.1016\/j.biopha.2024.117581_bib100","first-page":"1","article-title":"Inhibition of tumor cellular proteasome activity by triptolide extracted from the Chinese medicinal plant 'thunder god vine'","volume":"31","author":"Lu","year":"2011","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.biopha.2024.117581_bib101","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3892\/etm.2014.1729","article-title":"Triptolide induces apoptosis of breast cancer cells via a mechanism associated with the Wnt\/\u03b2-catenin signaling pathway","volume":"8","author":"Shao","year":"2014","journal-title":"Exp. Ther. Med."},{"issue":"5","key":"10.1016\/j.biopha.2024.117581_bib102","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3892\/ijo.2013.1843","article-title":"Role of oxidative stress, endoplasmic reticulum stress and ERK activation in triptolide-induced apoptosis","volume":"42","author":"Tan","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2024.117581_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/biom8040163","article-title":"Triptolide decreases cell proliferation and induces cell death in triple negative MDA-MB-231 breast cancer cells","volume":"8","author":"Varghese","year":"2018","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.biopha.2024.117581_bib104","first-page":"3413","article-title":"Triptolide induces autophagy and apoptosis through ERK activation in human breast cancer MCF-7 cells","volume":"15","author":"Gao","year":"2018","journal-title":"Exp. Ther. Med"},{"issue":"4","key":"10.1016\/j.biopha.2024.117581_bib105","first-page":"613","article-title":"Proteases as prognostic markers in cancer","volume":"2","author":"Duffy","year":"1996","journal-title":"Clin. Cancer Res"},{"issue":"12","key":"10.1016\/j.biopha.2024.117581_bib106","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/35103068","article-title":"Rho-family GTPases in cadherin-mediated cell-cell adhesion","volume":"2","author":"Fukata","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.biopha.2024.117581_bib107","first-page":"1043","article-title":"Triptolide inhibits breast cancer cell metastasis through inducing the expression of miR-146a, a negative regulator of Rho GTPase","volume":"27","author":"Liu","year":"2019","journal-title":"Oncol. Res. Featur. Preclin. Clin. Cancer Ther."},{"issue":"10","key":"10.1016\/j.biopha.2024.117581_bib108","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat. Med"},{"issue":"5","key":"10.1016\/j.biopha.2024.117581_bib109","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.3892\/or.2014.3115","article-title":"Triptolide-induced in vitro and in vivo cytotoxicity in human breast cancer stem cells and primary breast cancer cells","volume":"31","author":"Li","year":"2014","journal-title":"Oncol. Rep."},{"issue":"23","key":"10.1016\/j.biopha.2024.117581_bib110","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1158\/0008-5472.CAN-16-3452","article-title":"MYC Inhibition depletes cancer stem-like cells in triple-negative breast cancer","volume":"77","author":"Yang","year":"2017","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.biopha.2024.117581_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9050482","article-title":"Celastrol and triptolide suppress stemness in triple negative breast cancer: notch as a therapeutic target for stem cells","volume":"9","author":"Ramamoorthy","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.biopha.2024.117581_bib112","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12929-017-0398-9","article-title":"Preclinical and clinical aspects of TNF-\u03b1 and its receptors TNFR1 and TNFR2 in breast cancer","volume":"24","author":"Mart\u00ednez-Reza","year":"2017","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2024.117581_bib113","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.3892\/mmr.2016.4931","article-title":"Triptolide sensitizes human breast cancer cells to tumor necrosis factor-\u03b1-induced apoptosis by inhibiting activation of the nuclear factor-\u03baB pathway","volume":"13","author":"Cheng","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"17","key":"10.1016\/j.biopha.2024.117581_bib114","doi-asserted-by":"crossref","first-page":"23933","DOI":"10.18632\/oncotarget.8207","article-title":"Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2\/REST pathway in human breast cancer","volume":"7","author":"Xiong","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.biopha.2024.117581_bib115","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/mc.22795","article-title":"Triptolide sensitizes breast cancer cells to Doxorubicin through the DNA damage response inhibition","volume":"57","author":"Deng","year":"2018","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.biopha.2024.117581_bib116","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.biopha.2018.11.008","article-title":"Triptolide interferes with XRCC1\/PARP1-mediated DNA repair and confers sensitization of triple-negative breast cancer cells to cisplatin","volume":"109","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2024.117581_bib117","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2024.117581_bib118","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2006-10-051482","article-title":"Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway","volume":"110","author":"Liu","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.biopha.2024.117581_bib119","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.canlet.2008.05.025","article-title":"Triptolide inhibits interferon-\u03b3-induced programmed death-1-ligand 1 surface expression in breast cancer cells","volume":"270","author":"Liang","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2024.117581_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110346","article-title":"Codelivery of triptolide and IFN-\u03b3 to boost antitumor immunity for triple-negative breast cancer","volume":"120","author":"Cai","year":"2023","journal-title":"Int Immunopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117581_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020376","article-title":"The effect of triptolide in rheumatoid arthritis: from basic research towards clinical translation","volume":"19","author":"Fan","year":"2018","journal-title":"Int J. Mol. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224014677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224014677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:13:06Z","timestamp":1773969186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224014677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":121,"alternative-id":["S0753332224014677"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117581","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential antitumor activity of triptolide and its derivatives: Focused on gynecological and breast cancers","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117581"}}